Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Jazz Pharmaceuticals price target raised to $219 from $147 at Piper Sandler
20d ago
JAZZ
Premium
The Fly
Booking, Carvana upgraded: Wall Street’s top analyst calls
1M ago
H
MS
Premium
The Fly
Jazz Pharmaceuticals downgraded to Neutral from Buy at UBS
1M ago
JAZZ
Premium
Ratings
Hold Rating for Jazz Pharmaceuticals Amid Balanced Risk-Reward and Competitive Challenges
1M ago
JAZZ
Premium
The Fly
Zymeworks price target raised to $40 from $30 at Stifel
1M ago
JAZZ
ZYME
Premium
Ratings
Strong Buy Rating for Jazz Pharmaceuticals Driven by Promising Ziihera Drug and Positive Market Outlook
1M ago
JAZZ
Premium
The Fly
Truist ups Jazz Pharmaceuticals price target, says Ziihera is pipeline-in-a drug
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $209 from $160 at Baird
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $247 from $230 at BofA
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $170 at Wells Fargo
1M ago
JAZZ
Premium
Ratings
Jazz Pharmaceuticals’ Promising Pipeline and Strong Trial Results Lead to Buy Rating and Raised Price Objective
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $225 from $185 at Jefferies
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals rises 20.6%
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $194 from $155 at RBC Capital
1M ago
JAZZ
Premium
Ratings
Promising Phase 3 Trial Results and Expanding Indications Drive Buy Rating for Jazz Pharmaceuticals
1M ago
JAZZ
Premium
The Fly
Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley
1M ago
ONC
JAZZ
Premium
The Fly
Jazz Pharmaceuticals rises 20.8%
1M ago
JAZZ
Premium
Ratings
Promising HERIZON-GEA Trial Results Drive Buy Rating for Jazz Pharmaceuticals’ Ziihera
1M ago
JAZZ
Premium
Company Announcements
Jazz Pharmaceuticals Announces Positive Phase 3 Trial Results
1M ago
8K
JAZZ
Premium
The Fly
Jazz Pharmaceuticals announces top-line results from HERIZON-GEA-01 trial
1M ago
JAZZ
Premium
The Fly
Zymeworks’ Ziihera shows efficacy in Phase 3 adenocarcinoma trial
1M ago
ONC
JAZZ
Premium
Company Announcements
Jazz Pharmaceuticals Reports Record Revenue and Strategic Gains
2M ago
JAZZ
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
